Impact of left ventricular hypertrophy on myocardial injury in patients with ST-segment elevation myocardial infarction

Clinical Research in Cardiology : Official Journal of the German Cardiac Society
Thomas StiermaierIngo Eitel

Abstract

Left ventricular hypertrophy (LVH) has been suggested as a determinant of outcome in patients with ST-segment elevation myocardial infarction (STEMI). However, available data are inconclusive and the underlying mechanisms remain unclear. Therefore, the aim of this study was to evaluate the impact of LVH on myocardial injury and clinical outcome in a large multicenter STEMI population. Cardiovascular magnetic resonance was performed in 795 patients within 10 days after STEMI to assess left ventricular (LV) mass and parameters of myocardial injury. Gender-specific cutoff values of indexed LV mass were used to define LVH (67 g/m2 for men and 61 g/m2 for women). Rates of major adverse cardiac events (MACE) were determined at 12-month follow-up. LVH was present in 438 patients (55%) and associated with a significantly larger infarct size [18.3% of LV mass (%LV) versus 14.0%LV; p < 0.01], a lower myocardial salvage index (47.8 versus 54.4; p < 0.01), larger extent of microvascular obstruction (0.4 versus 0%LV; p < 0.01) and lower LV ejection fraction (47.9 versus 53.2%; p < 0.01) compared to STEMI patients without LVH. The effect of LVH on LV ejection fraction, infarct size and myocardial salvage index remained statistically signific...Continue Reading

References

Apr 15, 1987·The American Journal of Cardiology·D LevyW P Castelli
Oct 3, 2003·Journal of the American College of Cardiology·Teresa S M TsangJames B Seward
Oct 11, 2005·The American Journal of Cardiology·Alina GeorgescuUNKNOWN Assessment of the Safety and Efficacy of a New Thrombolytic Regimen Trial (ASSENT-3) Investigators
Apr 25, 2006·Journal of the American College of Cardiology·Holger ThieleGerhard Schuler
Jun 30, 2007·European Heart Journal·Cynthia M WesterhoutUNKNOWN GUSTO IV ACS Investigators
Jan 12, 2010·Circulation. Cardiovascular Imaging·Michel G KhouriMark H Drazner
Apr 7, 2010·American Heart Journal·Holger ThieleUNKNOWN Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) Investigato
Aug 28, 2012·European Heart Journal·UNKNOWN Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)Doron Zahger
Sep 23, 2014·Journal of the American College of Cardiology·Ingo EitelHolger Thiele
Dec 3, 2014·Journal of the American College of Cardiology·Rodrigo Fernández-JiménezBorja Ibáñez
May 1, 2015·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Nadine Kawel-BoehmDavid A Bluemke
May 15, 2015·Circulation Research·Han W KimRaymond J Kim
Jul 16, 2015·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Ingo EitelH Thiele

❮ Previous
Next ❯

Citations

Jul 7, 2019·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Sören J BackhausIngo Eitel
Sep 12, 2018·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Johannes H RiffelMatthias G Friedrich
Feb 3, 2019·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Jaroslaw ZalewskiAnetta Undas
Apr 17, 2020·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Martin ReindlSebastian J Reinstadler
Jan 24, 2021·The International Journal of Cardiovascular Imaging·Johannes H RiffelFlorian Andre
Mar 2, 2021·Gerontology & Geriatric Medicine·Yihe Wang, Gary S Newsome

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.